← back to search

Yesilda Balavarca

Biostatistical Consulting (United States) · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Epigenetics and DNA Methylation, Colorectal Cancer Screening and Detection, Genetic factors in colorectal cancer, and Pancreatic and Hepatic Oncology Research.
h-index
25
citations
1,713
works
77
NIH funding
primary concept
email

Recent publications

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
Clinical and Translational Gastroenterology 2022cited by 6position: middledoi
Associations between Genetic Variants and Blood Biomarkers of One-Carbon Metabolism in Postmenopausal Women from the Women's Health Initiative Observational Study.
PubMed 2022cited by 3position: middledoi
Associations between Genetic Variants and Blood Biomarkers of One-Carbon Metabolism in Postmenopausal Women from the Women's Health Initiative Observational Study
Journal of Nutrition 2021cited by 6position: middledoi
Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
Clinical and Translational Medicine 2020cited by 24position: middledoi
Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients
International Journal of Molecular Sciences 2020cited by 17position: middledoi
Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests
The American Journal of Gastroenterology 2020cited by 11position: middledoi
Screening for Colorectal Cancer—A German Perspective
The American Journal of Gastroenterology 2020cited by 2position: middledoi
Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
The American Journal of Gastroenterology 2019cited by 109position: middledoi
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study
BMC Medicine 2019cited by 55position: middledoi
Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening
The American Journal of Gastroenterology 2019cited by 40position: middledoi
Performance of individual and joint risk stratification by an environmental risk score and a genetic risk score in a colorectal cancer screening setting
International Journal of Cancer 2019cited by 34position: firstdoi
Significance of examined lymph node number in accurate staging and long-term survival in resected stage I-II pancreatic cancer: More is better? A large international population-based cohort study.
Journal of Clinical Oncology 2019cited by 14position: middledoi
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
BMC Medicine 2018cited by 129position: middledoi
Genetic Risk Score Is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer Screening Population
Gastroenterology 2018cited by 75position: middledoi
Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003–2014: a large international population‐based study
International Journal of Cancer 2018cited by 38position: middledoi
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
British Journal of Cancer 2018cited by 32position: middledoi
From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America
International Journal of Cancer 2018cited by 27position: middledoi
Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles
Epigenetics 2018cited by 26position: middledoi
Pathway analysis of genetic variants in folate‐mediated one‐carbon metabolism‐related genes and survival in a prospectively followed cohort of colorectal cancer patients
Cancer Medicine 2018cited by 26position: middledoi
Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation
Journal of Clinical Epidemiology 2018cited by 14position: middledoi
Survival of resected and overall pancreatic cancer patients in Europe and USA in 2003-2014: An international large-scale population-based investigation.
Journal of Clinical Oncology 2018cited by 0position: middledoi
Chemotherapy and radiotherapy application for pancreatic cancer in Europe and USA: An international population-based study.
Journal of Clinical Oncology 2018cited by 0position: middledoi
Survival-associated factors and a prognostic nomogram in resected pancreatic cancer: A large international population-based cohort study
Annals of Oncology 2018cited by 0position: middledoi
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Gut 2017cited by 223position: middledoi
Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study
Carcinogenesis 2017cited by 137position: middledoi
Administration of adjuvant chemotherapy for stage<scp>II‐III</scp>colon cancer patients: An European population‐based study
International Journal of Cancer 2017cited by 48position: middledoi
Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes
Clinical Colorectal Cancer 2017cited by 30position: middledoi
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium
Cancer Epidemiology Biomarkers & Prevention 2017cited by 19position: middledoi
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients
International Journal of Cancer 2016cited by 78position: middledoi
Comparison and combination of blood DNA methylation at smoking‐associated genes and at lung cancer‐related genes in prediction of lung cancer mortality
International Journal of Cancer 2016cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hermann Brenner · Stanford University30 papers (2014–2022)Lina Jansen · Krebsregister Baden-Württemberg16 papers (2015–2020)Cornelia M. Ulrich · University of Utah15 papers (2014–2022)Petra Schrotz‐King · German Cancer Research Center12 papers (2016–2020)Dominique Scherer · Heidelberg University10 papers (2014–2020)Michael Hoffmeister · Festo (Germany)10 papers (2014–2022)V.E.P.P. Lemmens · Netherlands Comprehensive Cancer Organisation10 papers (2016–2019) · 8 papers (2017–2020)Alexis Ulrich · Lukaskrankenhaus8 papers (2015–2020)Lei Huang · Nanchang University8 papers (2018–2020) · 7 papers (2018–2019)Vesna Zadnik · University of Primorska7 papers (2018–2020)Barbara Burwinkel · German Cancer Research Center7 papers (2014–2020)Korbinian Weigl · IFT Institut für Therapieforschung7 papers (2018–2022)Jenny Chang‐Claude · Centre hospitalier universitaire de Québec7 papers (2014–2020)Axel Benner · Cancer Research And Biostatistics7 papers (2014–2020)Harlinde De Schutter · Stichting tegen Kanker7 papers (2018–2020)Petra Seibold · German Cancer Research Center6 papers (2014–2020) · 6 papers (2018–2019)Katharina Buck · Roche (Switzerland)6 papers (2014–2020)